摘要 |
<P>PROBLEM TO BE SOLVED: To provide a method to identify specific cancer populations and/or specific cancer patients who are most likely to respond to one or more anti-cancer therapies that target IGF1R. <P>SOLUTION: Methods for identifying patients whose cancers are likely to be responsive to IGF1R inhibitory anti-cancer therapy, along with methods for treating such patients are provided. Patients identified by the method can be treated with any of several known IGF1R inhibitory agents including antibodies, small molecule inhibitors and anti-sense nucleic acids. <P>COPYRIGHT: (C)2012,JPO&INPIT |